Navigation Links
ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
Date:4/30/2009

CONSHOHOCKEN, Pa., April 30 /PRNewswire/ -- ePharmaSolutions, a leading provider of clinical services and trial management technologies for the biopharmaceutical industry announced that it has been selected along with its client Genentech, Inc as the winner of the Bio-IT World Best Practice Award for it's Clinical Trial Portal solution. Winners were selected from 72 submissions in 7 categories by a peer reviewed panel of 14 expert judges. The ePharmaSolutions Clinical Trial Portal Solution won in the Clinical Trials Management category.

"We are absolutely thrilled that our application is recognized as the most innovative clinical trial management solution by such a distinguished panel of judges," stated Lance Converse, Founder and CEO of ePharmaSolutions. "We have worked exceptionally hard to develop solutions that help solve some of the industries biggest causes of study delays. This award validates our mission and strategy to provide to the industry with best in class solutions that facilitates ongoing communication and collaboration between all of the stakeholders in the clinical trial process," added Converse.

The Clinical Trial Portal was developed to provide pharmaceutical companies with a common technology platform to streamline and accelerate site selection, activation, training, patient recruitment and communication. In addition, the Clinical Trial Portal uses a federated user identity management model that provides users with one set of credentials across all sponsors to help reduce the amount of userIDs and passcodes that are typically required in this industry. The Clinical Trial Portal currently hosts 143,000 active clinical research users from 107 countries for the top 20 pharmaceutical companies in the world.

"To be selected along side such companies as Wyeth, GSK, Merck, Abbott and AstraZeneca is truly an honor," said Enrico DePaolis, President & Chief Operating Officer for ePharmaSolutions. "Our teams have been working exceptionally hard to develop solutions that meet our client needs, while ensuring they are simple and easy for sites to adopt and use. The credit really should go to them," added DePaolis.

In today's technology-driven clinical trials environment, sponsors and sites are required to use dozens of new technologies for every study they conduct, typically having to remember different user credentials for each technology. The Clinical Trial Portal helps streamline and systematize clinical trial workflow between sponsors and sites providing one userID and one URL for all of the studies they conduct while providing detailed and dashboard level reporting to help manage the entire process at the user, site, study and enterprise level.

About ePharmaSolutions, Inc.

ePharmaSolutions is a leading provider of technology-based clinical services that help improve the way sites are selected, trained, activated and supported to commence clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 143,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world. ePharmaSolutions is headquartered in Philadelphia, Pennsylvania. For more information call 610-832-9915 or visit www.epharmasolutions.com. For an interactive demonstration of the Clinical Trial Portal go to http://courses.epharmasolutions.com/diasomedemo/shortdemo.htm.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 Research and Markets has announced ... (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By Country ... ... forecasted to grow at a CAGR of 5.33% during 2016-2021 ... infectious diseases along with surging demand of digital thermometer. Apart from ...
(Date:2/22/2017)... Feb. 22, 2017 Oncternal Therapeutics, Inc., ... both rare and common malignancies, today announced the ... The company intends to use the proceeds to ... and to advance preclinical development of a new ... is a first-in-class anti-ROR1 monoclonal antibody being developed ...
(Date:2/22/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced that KCP-400 (RgIA4), a potent antagonist ... robust chronic pain relief and disease modifying effects ... the a9a10 nAChR as a new, non-opioid target ... were reported online in the February 20 th ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... A product of ... seem to derive a heart-protective benefit from eating soy foods, while others do not, ... men who are able to produce equol—a substance made by some types of “good” ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent ... those report that family members or friends have also commented about their poor ... loss wear hearing aids. One reason, suggested by 89 percent of American respondents, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Super-Sod will attend ... 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home Show ... , For the booth, grass seed plant manager Chris Roquemore constructed furniture from recycled ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Social media ... especially for hospitals and health systems. Smith & Jones’ delves into this insight and ... episode, President of Smith & Jones David Vener meets up with social media strategist ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a ... Medical University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, ... on Aging is a tremendous resource in our community. We are thrilled to participate ...
Breaking Medicine News(10 mins):